Pneumococcal 13 valent Conjugate Vaccine (NA)
Pfizer Ltd
Prevenar 13 Vaccine is a widely trusted pneumococcal conjugate vaccine designed to help protect against serious infections caused by Streptococcus pneumoniae. These infections can lead to life-threatening conditions such as pneumonia, meningitis, bloodstream infections (septicemia), and ear infections, especially in infants, young children, older adults, and people with weakened immunity.
This vaccine offers protection against 13 different strains of pneumococcal bacteria, making it a vital part of routine immunization schedules across the world. By stimulating the body’s natural immune response, Prevenar 13 helps the immune system recognize and fight pneumococcal bacteria before they cause severe illness.
Helps prevent serious pneumococcal diseases
Provides broad protection against 13 pneumococcal strains
Suitable for infants, children, adults, and elderly individuals
Reduces the risk of complications like pneumonia and meningitis
Clinically proven and recommended by healthcare professionals
Prevenar 13 is commonly recommended for:
Infants and young children as part of routine vaccination
Adults aged 50 years and above
People with chronic illnesses or weakened immune systems
Prevenar 13 has been extensively studied and is used globally in immunization programs. When administered by a healthcare professional, it is considered safe and effective, helping protect individuals and communities from serious pneumococcal infections.
⚠️ Important Note: Prevenar 13 Vaccine should only be taken under medical supervision. Dosage and schedule may vary based on age, medical history, and physician recommendation.
Pneumococcal 13 valent Conjugate Vaccine (NA)